ArticleFrontiers in oncology2020

Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition.

Kran Suknuntha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.